Bostal
Latest round
- Series B
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 15
About Bostal
, Ltd doing business named Bostal, is a drug release system drug and pharmaceutical preparation research and development outsourcing service provider that develops, manufactures, and markets innovative drugs and generic drugs. As of August 2023, the company employs about 400 employees. The company was established by Dr. Rong Liu and Weiqin Tong. It has two production bases in Guangzhou, a gas pedal industrial park, and an internationalized agent industrialization base, which covered 6,800 square meters, and 68,000 square meters, respectively. The company provides entecavir tablets used for the treatment of chronic adult hepatitis B (including patients with compensated and decompensated liver disease) with active viral replication, persistently elevated serum alanine aminotransferase (ALT), or histological evidence of active liver disease. Bostal also has a wide range of product research and development pipelines, with products covering the treatment of various major diseases, such as metabolic diseases, psychiatric disorders, malignant tumors, cardiovascular and cerebrovascular diseases, and more. The company has developed platforms of preparation technologies, including oral sustained and controlled release preparations, gastro retentive sustained-release preparation, solubilization of insoluble drugs, orodispersible films, long-acting injection implants, long-acting microsphere for injection, nano injectables, long-acting gel for injection, and liposome.
Who invested in Bostal
15 investors across 3 rounds
See all investors in Bostal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bostal
Who invested in Bostal?
Bostal has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bostal raised?
Bostal has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bostal last raise money?
Bostal's most recent round on record is a Series B, in Aug 2023.
What does Bostal do?
, Ltd doing business named Bostal, is a drug release system drug and pharmaceutical preparation research and development outsourcing service provider that develops, manufactures, and markets innovative drugs and generic drugs.
Where is Bostal headquartered?
Bostal is headquartered in Guangzhou, China.
Which VCs invest in companies like Bostal?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Bostal's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Bostal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.